Kursprognose für Acrivon Therapeutics, Inc. (ACRV)ACRVAcrivon Therapeutics, Inc.

Alphio's ACRV stock price prediction model matches the current Acrivon Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.57 (+0.24%). The 1-week path is $1.60 (+2.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Acrivon Therapeutics Inc is currently not a strong buy due to its low price and negative earnings, but it shows potential for recovery. The current price is $1.61, significantly below the 52-week high of $3.56, indicating a 14.8% position within its 52-week range. However, the RSI is at 27.156, suggesting the stock is oversold, which could indicate a potential rebound. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$19,042,000 in Q1 2026. The main risk is the ongoing negative earnings trend, as indicated by the EPS of -0.49 for Q1 2026, which may deter investors in the short term.

Acrivon Therapeutics, Inc. (ACRV) last closed at $1.5700001, losing -9.77%. These facts feed the 1-day and 1-week ACRV price prediction above.